Oct 17 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX :
* FDA GRANTS ORPHAN DRUG DESIGNATION FOR NEUREN'S NNZ-2591 TO TREAT ANGELMAN, PHELAN-MCDERMID AND PITT HOPKINS SYNDROMES
Oct 17 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX :
* FDA GRANTS ORPHAN DRUG DESIGNATION FOR NEUREN'S NNZ-2591 TO TREAT ANGELMAN, PHELAN-MCDERMID AND PITT HOPKINS SYNDROMES